Oyavas
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oyavas, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: EMA Authorised: Oyavas (bevacizumab) — STADA Arzneimittel AG
1 regulatory and trial event tracked for Oyavas, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: EMA Authorised: Oyavas (bevacizumab) — STADA Arzneimittel AG